Scar imaging using multislice computed tomography versus metabolic imaging by F-18 FDG positron emission tomography: A pilot study

International Journal of Cardiology

Volumn 168, Issue 2, 2013, Pages 739-745

  Dwivedi, Girish ^a   Al Shehri, Halia ^a   De Kemp, Robert A ^a   Ali, Iftikhar ^a   Alghamdi, Abdul Aziz ^a   Klein, Ran ^a   Scullion, Andrew ^a   Ruddy, Terrence D ^a   Beanlands, Rob S ^a   Chow, Benjamin J W ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

F 18 FDG positron emission tomography; Metabolic imaging; Multislice computed tomography; Myocardial viability; Scar imaging

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IOHEXOL;

AGED; ANATOMICAL SCAR IMAGING; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; FEMALE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE; HUMAN; INTERMETHOD COMPARISON; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; METABOLIC VIABILITY IMAGING; MULTIDETECTOR COMPUTED TOMOGRAPHY; MYOCARDIAL SCAR; MYOCARDIAL VIABILITY; PILOT STUDY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUALITATIVE RESEARCH; QUANTITATIVE STUDY; RIGHT CORONARY ARTERY; SCAR; SENSITIVITY AND SPECIFICITY;

F-18 FDG POSITRON EMISSION TOMOGRAPHY; METABOLIC IMAGING; MULTISLICE COMPUTED TOMOGRAPHY; MYOCARDIAL VIABILITY; SCAR IMAGING;

AGED; CICATRIX; CORONARY ARTERY DISEASE; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84885323300     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.09.218     Document Type: Article

References (38)

1. D'Egidio G, Nichol G, Williams K, et al. Identification of high-risk patients with increasing ischemic cardiomyopathy. JACC Cardiovasc Imaging 2009;2:1060-8.
2. Beanlands R,Nichol G, Huszti E, et al. PARR-2 Investigators. F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease. A randomized controlled trial (PARR-2). J Am Coll Cardiol 2007;50:2002-12.
3. Beanlands RS, Ruddy TD, deKemp RA, et al. PARR Investigators. Positron emission tomography and recovery following revascularization (PARR-1): the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function. J Am Coll Cardiol 2002;40:1735-43.
4. Beanlands RS, Hendry PJ,Masters RG, deKemp RA,Woodend K, Ruddy TD. Delay in revascularization is associatedwith increasedmortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging. Circulation 1998;98:II51-6.
5. Zhang X, Liu XJ, Wu Q, et al. Clinical outcome of patients with previous myocardial infarction and left ventricular dysfunction assessed with myocardial (99m) Tc-MIBI SPECT and (18)F-FDG PET. J Nucl Med 2001;42:1166-73.
6. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002;39: 1151-8.
7. Jones RH, Velazquez EJ, Michler RE, et al. Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med 2009;360:1705-17.
8. Schinkel AF, Poldermans D, Rizzello V, et al. Incidence of recovery of contractile function following revascularization in patients with ischemic left ventricular dysfunction. Am J Cardiol 2004;93:14-7.
9. Camici PG, Prasad SK, Rimoldi OE. Stunning, hibernation, and assessment of myocardial viability. Circulation 2008;117:103-14.
10. Slart RH, Bax JJ, van Veldhuisen DJ, et al. Prediction of functional recovery after revascularization in patients with coronary artery disease and left ventricular dysfunction by gated FDG-PET. J Nucl Cardiol 2006;13:210-9.
11. Hillenbrand HB, Kim RJ, Parker MA, Fieno DS, Judd RM. Early assessment of myocardial salvage by contrast enhanced magnetic resonance imaging. Circulation 2000;102:1678-83.
12. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100:1992-2002.
13. Rochitte CE, Lima JA, Bluemke DA, et al. Magnitude and time course of microvascular obstruction and tissue injury after acutemyocardial infarction. Circulation 1998;98:1006-14.
14. Beanlands RS, Chow BJ, Dick A, et al. CCS/CAR/CANM/CNCS/CanSCMR joint position statement on advanced noninvasive cardiac imaging using positron emission tomography, magnetic resonance imaging and multidetector computed tomogramphic angiography in the diagnosis and evaluation of ischemic heart disease -executive summary. Can J Cardiol 2007;23:107-19.
15. Mahnken Andreas H, Koos Ralf, et al. Assessment of myocardial viability reperfused acute myocardial infarction using 16-slice computed tomography in comparison to magnetic resonance imaging. J Am Coll Cardiol 2005;45:2042-7.
16. Anselm DD, Anselm AH, Renaud J, et al. Altered myocardial glucose utilization and the reverse mismatch pattern on rubidium-82 perfusion/F-18-FDG PET during the sub-acute phase following reperfusion of acute anterior myocardial infarction. J Nucl Cardiol 2011;18:657-67.
17. Cerqueira MD, Weissman NJ, Dilsizian V, et al. American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals fromthe Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105:539-42.
18. Lee IH, Choe YH, Lee KH, Jeon ES, Choi JH. Comparison of multidetector CT with F-18-FDG-PET and SPECT in the assessment of myocardial viability in patients with myocardial infarction: a preliminary study. Eur J Radiol 2009;72:401-5.
19. Mahnken AH, Koos R, Katoh M, et al. Assessment of myocardial viability in reperfused acute myocardial infarction using 16-slice computed tomography in comparison to magnetic resonance imaging. J Am Coll Cardiol 2005;45:2042-7.
20. Baks T, Cademartiri F, Moelker AD, et al. Multislice computed tomography and magnetic resonance imaging for the assessment of reperfused acute myocardial infarction. J Am Coll Cardiol 2006;48:144-52.
21. Nikolaou K, Sanz J, Poon M, et al. Assessment of myocardial perfusion and viability from routine contrast-enhanced 16-detector-row computed tomography of the heart: preliminary results. Eur Radiol 2005;15:864-71.
22. Gerber BL, Belge B, LegrosGJ, et al. Characterization of acute and chronicmyocardial infarcts by multidetector computed tomography: comparison with contrast-enhanced magnetic resonance. Circulation 2006;113:823-33.
23. Jennings RB, Schaper J, Hill ML, Steenbergen CJ, Reimer KA. Effect of reperfusion late in the phase of reversible ischemic injury. Changes in cell volume, electrolytes, metabolites, and ultrastructure. Circ Res 1985;56:262-78.
24. Habis M, Capderou A, Ghostine S, et al. Acute myocardial infarction early viability assessment by 64-slice computed tomography immediately after coronary angiography: comparisonwith low-dose dobutamine echocardiography. J Am Coll Cardiol 2007;49: 1178-85.
25. Lardo AC, CordeiroMA, Silva C, et al. Contrast-enhanced multidetector computed tomography viability imaging aftermyocardial infarction: characterization ofmyocyte death, microvascular obstruction, and chronic scar. Circulation 2006;113:394-404.
26. Yoshida K, Gould KL. Quantitative relation ofmyocardial infarct size and myocardial viability by positron emission tomography to left ventricular ejection fraction and 3-yearmortality with and without revascularization. J Am Coll Cardiol 1993;22:984.
27. VomDahl J, Altehoefer C, Sheehan FH, et al. Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease. J Nucl Med 1997;38:742-8.
28. Desideri A, Cortigiani L, Christen AI, et al. The extent of perfusion-F18-fluorodeoxyglucose positron emission tomography mismatch determines mortality inmedically treated patients with chronic ischemic left ventricular dysfunction. J Am Coll Cardiol 2005;46:1264-9.
29. Di Carli M, Maddahi J, Rokhsar S, et al. Long-term survival of patients with coronary artery disease and left ventricular dysfunction: implications for the role of myocardial viability assessment in management decisions. J Thorac Cardiovasc Surg 1998;116:997-1004.
30. Hutyra M, Skála T, Kamínek M, et al. Comparison of two-dimensional longitudinal strain with rest single photon emission tomography perfusion imaging for transmural scar identification in patients with ischemic left ventricular systolic dysfunction. Int J Cardiol 2012;156:331-2.
31. Ono H, Funabashi N, Uehara M, et al. Comprehensive evaluation of characteristics of left ventricular myocardium in a subject with non-coronary arterial cardiac dysfunction through segment by segment analysis using various diagnostic modalities. Int J Cardiol 2010;145:95-100.
32. Pagano D, Lewis M, Townend J, Davies P, Camici P, Bonser R. Coronary revascularization for postischaemic heart failure: how myocardial viability affects survival. Heart 1999;82:684-8.
33. Di Carli MF, Davidson M, Little R, et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994;73:527-33.
34. Afridi I, Kleiman NS, Raizner AE, Zoghbi WA. Dobutamine echocardiography in myocardial hibernation: optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation 1995;91:663-70.
35. Hamdan A, Zafrir N, Sagie A, Kornowski R. Modalities to assess myocardial viability in the modern cardiology era. Coron Artery Dis 2006;17:567-76.
36. Kim RJ, Wu EW, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343: 1445-53.
37. Sanz J, Weeks D, Nikolaou K, et al. Detection of healed myocardial infarction with multidetector-row computed tomography and comparison with cardiac magnetic resonance delayed hyperenhancement. Am J Cardiol 2006;98:149-55.
38. Yoshida N, Funabashi N, Uehara M, et al. Differentiation of diagnosis and prognoses of non coronary arterial primary myocardial diseases with left ventricular focal myocardial thinning evaluated by multislice computed tomography. Int J Cardiol 2010;145:277-81.